Skip to content

Povidone Iodine Irrıgation at Hip-Knee Arthroplasty

Evaluation of the Systemic Effect of Intraoperative Diluted Povidone Iodine Irrigation Using Urine Iodine and Thyroid Function Tests in Patients Undergoing Knee-Hip Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05599841
Enrollment
120
Registered
2022-10-31
Start date
2019-01-01
Completion date
2023-09-16
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism, Iodine Toxicity, Osteoarthritis

Brief summary

Povidone iodine (PI) solution is an antimicrobial solution that can be used at hip and knee arthroplasty cases. It contains iodine that may be absorbed by the body. This study aims to investigate any absorption caused by PI solution.

Interventions

PROCEDUREPI solution

3,000 cc of \<2% concentrated povidone iodine solution will be used as irrigation solution at primary hip/knee arthroplasty. The PI solution was left in the joint for 3 minutes.

PROCEDURESaline Solution

3,000 cc of 0.9% saline solution will be used as irrigation solution at primary hip/knee arthroplasty. The saline solution was left in the joint for 3

Sponsors

Ankara University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with hip/knee osteoarthritis who undergo primary arthroplasty

Exclusion criteria

* Patients with abnormal thyroid function tests in the preoperative period, a history of the previous thyroid-related disease.

Design outcomes

Primary

MeasureTime frameDescription
Urine iodine levelpostoperative first dayUrine iodine concentration

Secondary

MeasureTime frameDescription
Thyroid hormonepostoperative 14 daysBlood thyroid hormone levels including: TSH, T3 and T4

Countries

Turkey (Türkiye)

Contacts

Primary ContactHakan Kocaoglu, MD
kocaoglu@ankara.edu.tr00903125082321

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026